THE WOODLANDS, Texas, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the company will host a virtual webcast: “LX9211 - Changing the Paradigm for ...
Background Best current estimates of neuropathic pain (NeuP) prevalence come from ... minimum duration (one year); number of trials of drugs of known effectiveness (four); adequate duration ...